Medicines/Supplements

Browse by Category

Pink Viagra

Did Hype Drive the FDA Decision on Women’s Libido Drug

Did Hype Drive the FDA Decision on Women’s Libido Drug

The FDA has approved Addyi (flibanserin), the first drug to treat low libido in premenopausal women who are diagnosed with hypoactive sexual desire disorder (HSDD), otherwise known as low sex drive. According to the FDA press release, the drug is being approved with a risk evaluation and mitigation strategy (REMS),…

Executive Director, DES Action USA Available for Comment on Pink Viagra & FDA Approval

Executive Director, DES Action USA Available for Comment on Pink Viagra & FDA Approval

Advocacy group cites connection between experimental drug flibanserin and world’s first synthetic estrogen, cause of DES Tragedy NEW YORK CITY, NY, June 15, 2015 – Suzanne Robotti, a DES Daughter and the Executive Director for DES Action USA, a nonprofit that advocates for DES-exposed individuals, is available to discuss concerns…

‘Pink Viagra’? Why We Shouldn’t Rush to ‘Fix’ Women’s Bodies

‘Pink Viagra’? Why We Shouldn’t Rush to ‘Fix’ Women’s Bodies

By Kari Christianson Program Director, DES Action USA Pink Viagra – Really?! The Food and Drug Administration has been seeking input from women about the condition “Female Sexual Dysfunction.” This is a fairly new term for low libido in women and has not been recognized by the American Psychiatric Association….

  • Advertisement